What is Axogen's stock issuance proceeds?

Axogen (AXGN) reported stock issuance proceeds of $134.04M in Q1 2026.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Axogen AXGN Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Baxter InternationalBAX

$8M-20.0%

LeMaitre VascularLMAT

$2.95M+125%

EnovisENOV

$628K+84.2%

MedtronicMDT

$97M-10.2%

Other financials

Income statement

See full

Revenue$61.5M+26.6%

Gross profit$46.2M+32.2%

Operating income-$2.8M-70.5%

Net income-$19.6M-411%

EPS (diluted)-$0.38-375%

Balance sheet

See full

Cash & equivalents$84.7M+251%

Total debt$20.6M-69.8%

Total equity$244.8M+132%

Total assets$289.5M+47.6%

Cash flow

See full

Operating cash flow$1.6M+112%

CapEx$2.8M+989%

Free cash flow-$1.2M+90.9%

Valuation

See full

Market cap$2.26B+110%

Enterprise value$2.2B+91.4%

P/S9.5×+4.0×

Profitability

See full

Gross margin75%+0.8pp

Operating margin-3.8%—

Net margin-13.2%-22.8pp

FCF margin-12.9%-3.8pp

Returns & leverage

See full

Return on equity-18%-70.5pp

Debt / equity0.1×-0.6×

Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Axogen's stock issuance proceeds?: Axogen (AXGN) reported stock issuance proceeds of $134.04M in Q1 2026.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.